Загрузка...
Is microfluidics the “assembly line” for CRISPR-Cas9 gene-editing?
Acclaimed as one of the biggest scientific breakthroughs, the technology of CRISPR has brought significant improvement in the biotechnological spectrum—from editing genetic defects in diseases for gene therapy to modifying organisms for the production of biofuels. Since its inception, the CRISPR-Cas...
Сохранить в:
| Опубликовано в: : | Biomicrofluidics |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AIP Publishing LLC
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7688342/ https://ncbi.nlm.nih.gov/pubmed/33262863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1063/5.0029846 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|